No Data
US Stock MarketDetailed Quotes
BTG B2Gold
Watchlist
3.100
-0.010-0.32% Close 09/22 16:00 ET
3.090-0.010-0.32%
Post 16:07 ET
3.150High3.080Low5.95MVolume
3.120Open3.110Pre Close18.48MTurnover0.46%Turnover Ratio11.48P/E (TTM)4.02BMarket Cap4.29752wk High12.92P/E (Static)1.30BShares2.68152wk Low1.00P/B3.98BFloat Cap6.619Historical High0.16Dividend TTM1.29BShs Float0.513Historical Low5.16%Div YieldTTM2.25%Amplitude3.106Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About B2Gold Company
B2Gold Corp. is an exploration company, which engages in the acquisition and development of mineral properties. It operates through the following segments: Fekola Mine, Otjikoto Mine, Masbate Mine, Libertad Mine, and Limon Mine. The company was founded by Mark Anthony Corra, Thomas A. Garagan, Clive Thomas Johnson and Roger Thomas Richer on November 30, 2006 and is headquartered in Vancouver, Canada.
Revenue Breakdown
Business
Unit:USD
Stock NameYOYOperating income%
Fekola Mine--1.07B61.61%
Masbate Mine--384.71M22.20%
Otjikoto Mine--280.39M16.18%
News
B2Gold's (BTG) Goose Project Set to Pour First Gold in 1Q25
National Bank of Canada Says M&A Sentiment Muted During 2023 Denver Gold Forum
National Bank of Canada said Wednesday that speculation on deals seemed limited during the 2023 Denver Gold Forum, and sentiment seemed to have favored brownfield expansion projects by multiple compan
Unveiling B2Gold Corp's Dividend Performance: An In-depth Analysis
Comments
$B2Gold(BTG.US$ [Closed]
•Entry (Buy): 3.46
07Jun
•SL @ 3.26 (move 50% SL @ 3.67 20Jul)
•50% TP set @ 3.67 11Jul
•Bal 50% TP (set @ 4.08 11Jul)
* For my own record (NFA/DYODD)
$E-mini S&P 500 Futures(DEC3)(ESmain.US$$E-mini NASDAQ 100 Futures(DEC3)(NQmain.US$$E-mini Dow Futures(DEC3)(YMmain.US$
•Entry (Buy): 3.46
07Jun•SL @ 3.26 (move 50% SL @ 3.67 20Jul)
•50% TP set @ 3.67
11Jul•Bal 50% TP (set @ 4.08 11Jul)
* For my own record (NFA/DYODD)
$E-mini S&P 500 Futures(DEC3)(ESmain.US$$E-mini NASDAQ 100 Futures(DEC3)(NQmain.US$$E-mini Dow Futures(DEC3)(YMmain.US$
ColumnsToday's pre-market stock movers: TSLA, JPM, NVAX, CAG and more
Gainers:
• $Theravance Biopharma(TBPH.US$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners(GRBK.US$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
• $Theravance Biopharma(TBPH.US$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners(GRBK.US$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
10
1
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--